Ultragenyx Pharmaceutical Inc. (RARE) 13D/13G Filings for Arcturus Therapeutics Holdings Inc. (ARCT)

Ultragenyx Pharmaceutical Inc. 13D and 13G filings for Arcturus Therapeutics Holdings Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-10-26
4:44 pm
Sale
2021-10-2113DArcturus Therapeutics Holdings Inc.
ARCT
Ultragenyx Pharmaceutical Inc.
RARE
1,200,000
4.600%
-200,000decrease
(-14.29%)
Filing
2021-08-12
5:09 pm
Sale
2021-08-1013DArcturus Therapeutics Holdings Inc.
ARCT
Ultragenyx Pharmaceutical Inc.
RARE
1,400,000
5.300%
-800,000decrease
(-36.36%)
Filing
2020-12-10
4:51 pm
Sale
2020-12-0813DArcturus Therapeutics Holdings Inc.
ARCT
Ultragenyx Pharmaceutical Inc.
RARE
2,200,000
9.000%
-800,000decrease
(-26.67%)
Filing